BioMarin Pharmaceutical Inc. buy Morgan Stanley
Start price
27.04.26
/
50%
€45.91
Target price
27.04.27
€102.34
Performance (%)
15.44%
Price
27.07.26
€53.00
Summary
This prediction is currently active. The prediction currently has a performance of 15.44%. This prediction currently runs until 27.04.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | 2.356% | 2.356% |
| iShares Core DAX® | 2.992% | 3.220% |
| iShares Nasdaq 100 | -1.584% | -3.172% |
| iShares Nikkei 225® | -2.254% | -9.924% |
| iShares S&P 500 | -0.009% | 1.641% |
Comments by Morgan_Stanley for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (BMRN) is now covered by Morgan Stanley. They set an "overweight" rating and a $120.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Morgan_Stanley for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€45.70
05.05.26
05.05.26
€101.82
05.05.27
05.05.27
15.97%
27.07.26
27.07.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.90
28.10.25
28.10.25
€84.06
28.10.26
28.10.26
13.01%
27.07.26
27.07.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€50.36
22.07.25
22.07.25
€82.12
22.07.26
22.07.26
0.91%
23.07.26
23.07.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€48.80
03.07.25
03.07.25
€82.17
03.07.26
03.07.26
5.94%
04.07.26
04.07.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€75.64
26.04.24
26.04.24
€104.69
26.04.25
26.04.25
-26.63%
27.04.25
27.04.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€79.72
01.08.23
01.08.23
€113.91
01.08.24
01.08.24
-3.59%
02.08.24
02.08.24